# OnCo record propranolol-hemangeol (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/propranolol-hemangeol/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "propranolol-hemangeol" ;
  schema:name "Propranolol (Hemangeol)"@en ;
  schema:alternateName "Propranolol Hydrochloride"@en, "Propranolol oral solution"@en, "Hemangeol" ;
  schema:description "Hemangeol is a liquid form of the blood-pressure drug propranolol approved to shrink infantile haemangiomas, the common benign blood-vessel tumours of babies, replacing steroids and surgery for most children who need treatment."@en ;
  schema:url <https://onco.cc/drugs/propranolol-hemangeol/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Propranolol> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=propranolol%20hydrochloride%20oral%20solution>, <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205410> ;
  onco:status "established" ;
  onco:tag "gap-fill", "supportive-care" ;
  onco:modality "Small-molecule non-selective beta-adrenergic blocker, oral solution" ;
  onco:approval "US 2014: Proliferating infantile haemangioma requiring systemic therapy" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/fronts/supportive-care/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:companies <https://onco.cc/companies/pierre-fabre/> ;
  onco:trials <https://onco.cc/trials/nct07125391/>, <https://onco.cc/trials/nct05741164/> .